I
GILD icon

InceptionR’s Gilead Sciences GILD Stock Holding History

InceptionR’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
17,464
+13,173
+307% +$1.74M 0.54% 2
2026
Q1 		$598K Buy
+4,291
New +$601K 0.14% 252
2025
Q4 		– Sell
-3,622
Closed -$402K – 700
2025
Q3 		$402K Buy
+3,622
New +$412K 0.1% 380
2025
Q1 		– Sell
-17,143
Closed -$1.58M – 665
2024
Q4 		$1.58M Buy
17,143
+4,192
+32% +$377K 0.35% 66
2024
Q3 		$1.09M Buy
12,951
+7,347
+131% +$561K 0.27% 109
2024
Q2 		$384K Sell
5,604
-9,027
-62% -$602K 0.11% 355
2024
Q1 		$1.07M Buy
14,631
+7,903
+117% +$608K 0.28% 131
2023
Q4 		$545K Sell
6,728
-1,633
-20% -$127K 0.39% 88
2023
Q3 		$627K Buy
+8,361
New +$643K 0.36% 96
2023
Q1 		– Sell
-10,379
Closed -$891K – 488
2022
Q4 		$891K Buy
+10,379
New +$822K 0.47% 45

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

InceptionR's GILD Position: Q2 2026 in Review

InceptionR increased its Gilead Sciences (GILD) stake by 307% in Q2 2026, buying an estimated $1.74M and bringing the position to 17,464 shares worth $2.21M. The position accounts for 0.54% of the portfolio, ranked #2.

InceptionR first reported a position in GILD in Q4 2022 and has held it in 10 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • InceptionR held 17,464 shares of Gilead Sciences worth $2.21M as of Q2 2026.
  • InceptionR bought 13,173 Gilead Sciences shares in Q2 2026, an estimated $1.74M.
  • Gilead Sciences made up 0.54% of InceptionR's portfolio in Q2 2026, its #2 holding.
  • InceptionR first reported a position in Gilead Sciences in Q4 2022 and has held it in 10 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.